Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 7NIH 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2Thoracic 1Plasma cell 1Head & Neck 1Genitourinary 1Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Multiple Myeloma 93Neoplasms, Plasma Cell 22Immunoglobulin Light-chain Amyloidosis 19Waldenstrom Macroglobulinemia 10Lymphoma, Non-Hodgkin 9Leukemia, Lymphocytic, Chronic, B-Cell 9Recurrence 8Monoclonal Gammopathy of Undetermined Significance 8Lymphoma, Large-Cell, Immunoblastic 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Follicular 8Lymphoma, B-Cell, Marginal Zone 8Burkitt Lymphoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Mantle-Cell 7Lymphoma 7Leukemia, Myeloid, Acute 7Hodgkin Disease 7Thrombocythemia, Essential 6Primary Myelofibrosis 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Polycythemia Vera 6Pdgfra-Associated Chronic Eosinophilic Leukemia 6Lymphoma, T-Cell, Cutaneous 6Lymphoma, Large-Cell, Anaplastic 6Leukemia, Neutrophilic, Chronic 6Leukemia, Myeloid, Chronic-Phase 6Leukemia, Myeloid, Accelerated Phase 6Leukemia, Hairy Cell 6Blast Crisis 6

Interventions

Peripheral Blood Stem Cell Transplantation 1Melphalan 1Filgrastim 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Drug-Related Side Effects and Adverse Reactions × Plasma cell × Clear all
NCT00052884 2023-06-18

Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation

Eastern Cooperative Oncology Group

Phase 1 Terminated
8 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma, Neoplasms, Plasma Cell, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡